Advertisement Merck's Q2 income up - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Merck’s Q2 income up

Merck & Co has posted a net income of $1.77 billion for the second quarter of 2008, compared with $1.68 billion for the corresponding period of 2007.

Worldwide sales were $6.1 billion in the second quarter of 2008, a decrease of 1% from the second quarter of 2007. For the first six months of 2008, worldwide sales were $11.9 billion and net income was $5.07 billion.

Richard Clark, chairman, president and CEO of Merck, said: “For the second quarter, Merck made good progress launching innovative new pharmaceutical and vaccine products around the world and driving efficiencies in many parts of the business. Although some results didn’t meet our expectations, we are taking action to address our challenges, and remain committed to regaining leadership in the pharmaceutical industry.”